ABAC THERAPEUTICS
ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximize the chance of success in clinical development.
ABAC THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2014-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.abactherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(+34) 93 230 11 54
Total Funding:
16 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Grupo Ferrer Internacional
Grupo Ferrer Internacional investment in Series A - ABAC Therapeutics
Global health sciences venture fund
Global health sciences venture fund investment in Series A - ABAC Therapeutics
Pontifax
Pontifax investment in Series A - ABAC Therapeutics
Caixa Capital Risc
Caixa Capital Risc investment in Series A - ABAC Therapeutics
Debiopharm Innovation Fund
Debiopharm Innovation Fund investment in Series A - ABAC Therapeutics
Official Site Inspections
http://www.abactherapeutics.com Semrush global rank: 6.15 M Semrush visits lastest month: 1.31 K
- Host name: 172.67.192.233
- IP address: 172.67.192.233
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ABAC Therapeutics"
ABAC Therapeutics - Crunchbase Company Profile
ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial …See details»
ABAC Therapeutics 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for ABAC Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
ABAC Therapeutics Inc - Company Profile and News
Company profile page for ABAC Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
ABAC Therapeutics - VentureRadar
"ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we …See details»
ABAC Therapeutics - Company Profile - Tracxn
Feb 26, 2025 ABAC Therapeutics - Early stage biopharma developing precision drugs for MDR bacterial infections. Acquired by TIBIDABO VENTURES. Raised a total funding of $19.8M …See details»
ABAC Therapeutics: Contact Details and Business Profile
ABAC Therapeutics is committed to finding therapeutic solutions for patients that are infected with highly antibiotic-resistant bacterial pathogens and that leave affected patients with few (or no) …See details»
ABAC Therapeutics Overview | SignalHire Company Profile
Organization Website: abactherapeutics.com : Social Links: Phone Number: 34-93-230-11-54: ABAC Therapeutics industries Biotech, Biotechnology: Headquarters Location: C Joan XXIII …See details»
ABAC Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 15, 2018: Series A - ABAC …See details»
ABAC Therapeutics - Contacts, Employees, Board Members
Organization. ABAC Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 1. Number of Board Member and …See details»
ABAC Therapeutics SA Company Profile, Financial and ... - digitGaps
ABAC Therapeutics SA develops precision antimicrobial agents. The company offers therapeutic solutions for patients that are infected with highly antibiotic-resistant bacterial pathogens. …See details»
☑️ABAC Therapeutics — Consulting Organization from Spain, …
ABAC Therapeutics — Consulting Organization from Spain, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Laboratory & Measurement sectors. Our website uses …See details»
A B C Therapeutics Company Profile -Sales, Contacts, Competitors …
A B C Therapeutics is in the Occupational Therapist industry within the Health Services sector and has been in business for approximately 22 years.See details»
Four advances that could change tuberculosis treatment
Mar 21, 2025 The American Chemical Society (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the …See details»
A B C Therapeutics Pllc Company Profile | Akron, NY | Competitors ...
Find company research, competitor information, contact details & financial data for A B C Therapeutics Pllc of Akron, NY. Get the latest business insights from Dun & Bradstreet.See details»
Abac Therapeutics - Overview, CEO, Products, Business - Easyleadz
Abac Therapeutics is a private company and Abac Therapeutics is classified as a Non Government company. Abac Therapeutics is a Biotechnology based company and has …See details»
ABAC Therapeutics raises 16 million euros from investors including ...
Feb 15, 2018 Spain-based ABAC Therapeutics, a leader in pathogen-specific antibiotics, announced today the closing of a 16 million euros (~$20 million) Series A round.See details»
Abac Therapeutics - Academic Positions
About Us. ABAC Therapeutics team is committed to finding innovative therapeutic solutions to protect the lives of patients infected with AMR, and fight one of the most serious global health …See details»
Debiopharm continues the fight against antibiotic resistance with ...
Feb 15, 2018 ABAC develops new targeted antibiotics for patients with severe infections. Lausanne, Switzerland – February 15, 2018 – Debiopharm Group ™ announces an …See details»
ABAC Therapeutics: Scientists from Spain and India Lead an ...
Sep 13, 2022 Antimicrobial resistance (AMR) and the increase of multi-resistant bacteria is an ongoing threat to global public health, as the World Health Organization (WHO) warns. In …See details»
ABAC Therapeutics Announces €16 Million Series A to Develop …
Feb 15, 2018 MADRID and BARCELONA, Spain, February 15, 2018 /PRNewswire/ --. ABAC Therapeutics (ABAC), a leader in pathogen-specific antibiotics, announced today the closing …See details»